Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.